Tumor-associated macrophages (TAMs) are subdivided into two subsets, M1 and M2 macrophages, based on their capacity to express or produce Nitric Oxide Synthase/IL-12/TNF-α or arginase-1/IL-10/TGF-β, respectively. This evidence concerns the gene TGFB1 and neoplasm.